MLNT News
Archived Headlines
- 8 U.S. IPOs planned for the week of Jan 30 01/30/12
- Significant pricing activity ahead as six companies set IPO terms this week 01/20/12
- 2012 IPO calendar building with 10 deals planned, pre-IPO research available 01/18/12
- Biopharmaceutical maker Cempra, seeking $72 million, kicks off US roadshow 01/13/12
- Technology leads a week of 5 new US IPO filings, 5 IPOs added to the calendar 01/13/12
See more
A new pneumonia IPO: Nabriva Therapeutics files for a $92 million US IPO
Nabriva Therapeutics, which is developing a novel antibiotic for bacterial pneumonia, filed on Thursday with the SEC to raise up to $92 million in an initial public offering. The Vienna, Austria-based company, which was founded in 2005, plans to list on...read more
Cempra quiet period ends March 14
Cempra, a biotech developing potent antibiotics to fight pneumonia and skin infections, will see its quiet period end on 3/14/12. On 2/2/12, the company raised $50.4 million by offering 8,400,000 shares at $6.00, below the range of $11.00 to $13.00. Stifel...read more
Troubles for the energy industry detract from exciting week for US IPOs
For all the positive headlines (the Facebook announcement, the jobs report, the market rally), the end of January was a mixed bag for the US IPO market. The FTSE Renaissance US IPO Index (IPOS), up 15.4% year-to-date, maintained its stellar start to the year,...read more
Cempra prices IPO at $6, below the range
Cempra, a biotech developing potent antibiotics to fight pneumonia and skin infections, raised $50 million by offering 8.4 million shares at $6, below the range of $11 to $13. The company had originally planned to sell 6 million shares. Cempra plans to list on...read more